Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force

Affiliations

• ¹ Clinical Research Department, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), IIS-Fundación Jiménez Díaz University Hospital, and CIBERCV, Madrid, Spain.
• ² Department of Cardiology, Oslo University Hospital Ulleval and University of Oslo, Oslo, Norway.
• ³ Division of Cardiology, Geneva University Hospital, Geneva, Switzerland.
• ⁴ Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Instituto de investigación imas12 - Cardiology Department, Hospital Universitario 12 de Octubre, and Universidad Complutense de Madrid, Spain.
• ⁵ Department of Internal Medicine/Cardiology, Heart Center Leipzig, University Hospital, Leipzig, Germany.
• ⁶ Department of Cardiology and Critical Care Medicine, Hartcentrum Hasselt, Jessa Ziekenhuis, and Hasselt University, Hasselt, Belgium.
• ⁷ Division of Cardiology and Angiology II, University Heart Center Freiburg Bad Krozingen, Freiburg, Germany.
• ⁸ Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland.
• ⁹ Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Dag Hammarskjolds vag 14B SE-752 37, Uppsala, Sweden.